ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP)

44.51
-2.06
(-4.42%)
Closed 26 February 8:00AM
45.15
0.64
( 1.44% )
Pre Market: 10:16PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
40.004.004.904.804.45-5.75-54.50 %207026/2/2025
40.503.705.300.004.500.000.00 %00-
41.003.504.003.743.75-4.11-52.36 %111226/2/2025
41.504.605.807.805.200.000.00 %05-
42.003.905.104.634.500.000.00 %082-
42.503.604.709.744.150.000.00 %09-
43.001.254.001.792.625-2.09-53.87 %3009226/2/2025
43.502.853.602.603.2250.000.00 %0132-
44.002.453.103.832.7750.000.00 %058-
44.501.051.251.101.15-1.60-59.26 %122226/2/2025
45.001.752.251.932.00-1.00-34.13 %121326/2/2025
45.501.452.001.651.7250.000.00 %042-
46.001.201.702.081.450.000.00 %086-
46.500.400.500.400.45-0.95-70.37 %191826/2/2025
47.000.751.101.100.9250.000.00 %0160-
47.500.200.350.280.275-0.77-73.33 %33226/2/2025
48.000.350.700.650.525-0.20-23.53 %213126/2/2025
48.500.100.850.700.4750.000.00 %033-
49.000.050.200.150.125-0.50-76.92 %188926/2/2025
49.500.050.200.130.125-0.52-80.00 %54826/2/2025

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
40.000.050.450.050.250.000.00 %0104-
40.500.000.450.000.000.000.00 %00-
41.000.360.500.360.430.000.00 %034-
41.500.100.200.150.150.10200.00 %52326/2/2025
42.000.180.200.190.190.015.56 %16026/2/2025
42.500.250.400.400.3250.20100.00 %1726/2/2025
43.000.450.300.450.3750.000.00 %085-
43.500.250.400.300.3250.000.00 %017-
44.000.701.300.751.000.41120.59 %5146326/2/2025
44.500.400.750.330.5750.000.00 %018-
45.001.201.601.381.400.93206.67 %13921126/2/2025
45.500.751.050.850.900.1013.33 %12626/2/2025
46.000.901.250.951.0750.000.00 %0711-
46.502.103.302.142.700.9376.86 %46026/2/2025
47.002.602.852.572.7251.32105.60 %2655526/2/2025
47.503.003.301.403.150.000.00 %0108-
48.002.002.651.852.3250.000.00 %0268-
48.502.352.953.302.650.000.00 %029-
49.002.703.402.423.050.000.00 %0173-
49.503.203.802.163.500.000.00 %034-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ENVBEnveric Biosciences Inc
US$ 2.77
(134.75%)
17.7M
PITAHeramba Electric PLC
US$ 0.71
(92.41%)
13.47M
JCTCJewett Cameron Trading Company
US$ 7.64
(64.30%)
73
LSBKLake Shore Bancorp Inc
US$ 25.47
(59.11%)
4
HCTIHealthcare Triangle Inc
US$ 0.604
(58.95%)
14.89M
ADVMAdverum Biotechnologies Inc
US$ 1.73
(-58.81%)
21
CSPICSP Inc
US$ 9.12
(-41.87%)
12
SRBKSR Bancorp Inc
US$ 7.01
(-41.83%)
9
BSMWInvesco BulletShares 2032 Municipal Bond ETF
US$ 15.01
(-40.48%)
1
CSBRChampions Oncology Inc
US$ 6.06
(-36.74%)
5
ENVBEnveric Biosciences Inc
US$ 2.77
(134.75%)
17.7M
HCTIHealthcare Triangle Inc
US$ 0.604
(58.95%)
14.89M
PITAHeramba Electric PLC
US$ 0.71
(92.41%)
13.47M
ONVOOrganovo Holdings Inc
US$ 1.52
(19.69%)
6.73M
QVCGAQVC Group Inc
US$ 0.4156
(0.00%)
5.2M

CRSP Discussion

View Posts
jondoeuk jondoeuk 5 days ago
Looks pretty bullish for Casgevy https://www.businesswire.com/news/home/20250221469479/en/bluebird-bio-Announces-Definitive-Agreement-to-be-Acquired-by-Carlyle-and-SK-Capital
👍️0
TechandBio TechandBio 1 week ago
Added a chunk today to my stash average is now 42.00

$CRSP
👍️0
TechandBio TechandBio 1 week ago
Nice pre market action!

Very deep pipeline with a mega partner VRTX

$CRSP
👍️0
TechandBio TechandBio 2 weeks ago
Starting to turn the corner now!

Glad I re-loaded the low 40's

$CRSP
👍️ 1
jondoeuk jondoeuk 1 month ago
Anticipated 2025 milestones https://www.globenewswire.com/news-release/2025/01/13/3008308/0/en/CRISPR-Therapeutics-Highlights-Strategic-Priorities-and-Anticipated-2025-Milestones.html
👍️ 1
jondoeuk jondoeuk 1 month ago
Link to the webcast https://jpmorgan.metameetings.net/events/healthcare25/sessions/58421-crispr-therapeutics/webcast/general_signin?gpu_only=true&kiosk=true+%5Bjpmorgan.metameetings.net%5D
👍️ 1
jondoeuk jondoeuk 2 months ago
They will present at the 43rd Annual J.P. Morgan Healthcare Conference (Jan 14, at 2:15 PM PST).
👍️ 1
PonkenPlonken PonkenPlonken 3 months ago
cheap cheap
👍️ 1
jondoeuk jondoeuk 3 months ago
The PR https://www.globenewswire.com/news-release/2024/12/09/2993974/0/en/CRISPR-Therapeutics-Presents-Data-at-the-2024-American-Society-of-Hematology-ASH-Annual-Meeting.html

Poster https://ir.crisprtx.com/static-files/12114290-21a6-4544-9cb7-de4fe2852e94
👍️0
PonkenPlonken PonkenPlonken 3 months ago
Neglected ugly duckling. $NTLA, $VERV & $CRBU now do trials outside of the US.... Maybe sentiment change is on the horizon -- see below

"The CBER director also apologized for “mistakes” in how the FDA handled early work for in vivo gene therapies, which “led to offshoring of some of the trials.”"
https://endpts.com/fda-vaccine-chief-peter-marks-pledges-to-stay-as-long-as-hes-welcome/#:~:text=The%20CBER%20director%20also%20apologized,%E2%80%9Cit%20is%20really%20important.%E2%80%9D

CHEAP CHEAP
SRPT and BMS announcing nice CRISPR deals with ARWR and PRME should help this too!
👍️0
jondoeuk jondoeuk 3 months ago
CTX130 data in R/R T-cell lymphomas (peripheral T-cell lymphoma or cutaneous T-cell lymphoma) https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00508-4/abstract

The ORR was 46.2%. Of those treated at DL3 and higher, the ORR was 51.6%.
👍️ 1
PonkenPlonken PonkenPlonken 3 months ago
so so so undervalued and misunderstood i believe...... frankly just cheap
https://x.com/RNAiAnalyst/status/1859876294487363651
👍️ 1
jondoeuk jondoeuk 3 months ago
They now have the ability to put in eight to nine edits. So it is a single cassette that expresses the CAR, can express a cytokine and has an shRNA-like approach to knock down genes. So there's no theoretical limit as to the number of edits, but there may be marginal utility beyond a certain point.

Hopefully, they look to improve donor selection, cell selection and manufacturing, as all could increase efficacy.
👍️ 1
jondoeuk jondoeuk 4 months ago
ASH abstract https://ash.confex.com/ash/2024/webprogram/Paper203563.html
👍️0
jondoeuk jondoeuk 4 months ago
Q3 business update and financial results https://www.globenewswire.com/news-release/2024/11/05/2974996/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2024-Financial-Results.html
👍️0
Monksdream Monksdream 4 months ago
CRSP 10Q 11/5
👍️0
Monksdream Monksdream 4 months ago
CRSP under $50
👍️0
jondoeuk jondoeuk 4 months ago
OT: In this Dr. Urnov, PhD, laid out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies https://www.liebertpub.com/doi/10.1089/crispr.2024.0082
👍️ 1
TechandBio TechandBio 5 months ago
CRSP will climb tremendously over the years.
SMMT went from $1.00-30.00+ this year cancer drug superior to Mercks Keytruda
ICCM company being over looked that kills cancers by freezing them 97% non recurrence rate for breast cancer after 5 years and superior data to lung cancer safe cryoblation is done in less than hour.
https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html

https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html
👍️0
Monksdream Monksdream 5 months ago
Buy range again thanks a bunch
👍️0
Monksdream Monksdream 5 months ago
Buy range again thanks a bunch
👍️0
OldAIMGuy OldAIMGuy 5 months ago
Hi MD,
Here's a little longer view:


This might also be a cyclical low here. But, most of 2024 has shown severe distribution of shares until about the last month. That, at least, seems to be flattening out.
Best wishes,
OAG
👍️0
Monksdream Monksdream 5 months ago
CRSP trend since February remains bearish
👍️0
jondoeuk jondoeuk 7 months ago
Q2 results https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200100452.html
👍️0
lambchops lambchops 7 months ago
Hey Monk, Hopefully you bought some shares on Friday@ Sold at 10% discount!

LC

CRISPR!!!
👍️0
Monksdream Monksdream 7 months ago
CRSP under $75
👍️0
TechandBio TechandBio 8 months ago
Crispr added some $120 Vertical debit spreads in 2026

$CRSP
👍️ 1
axelvento axelvento 9 months ago
I agree.....solid company$$$$$$$$
👍️0
Monksdream Monksdream 9 months ago
It may take some time for CRSP returns to a $200 price tag
The same could be said for hundreds of other stocks that soared during Covid mania
Since then the stock has rallied from low points
With all that money the company has to do incredible things with its biotechnology the stock isn’t going to zero
👍️ 1
axelvento axelvento 10 months ago
Strong balance sheet with approximately $2.1 billion in cash, cash equivalents, and marketable securities as of March 31, 2024

https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000059.html
👍️0
jondoeuk jondoeuk 10 months ago
(OT): A new AI paper from Princeton and Stanford https://www.biorxiv.org/content/10.1101/2024.04.25.591003v2.full

CRISPR-GPT demonstrated a marked improvement in gene-editing experiments, increasing the accuracy of target gene modifications by up to 30% compared to conventional methods. In validation tests, it achieved a specificity rate exceeding 95%, with a significant reduction in off-targets. The system also reduced the time required to design and plan experiments by approximately 40%, streamlining the workflow for researchers.
👍️0
jondoeuk jondoeuk 10 months ago
Business Update and Q1 Financial Results https://uk.finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000300.html
👍️0
jondoeuk jondoeuk 10 months ago
Highlights (plus new programs utilising in vivo gene editing) https://finance.yahoo.com/news/crispr-therapeutics-highlights-asgct-oral-110000066.html
👍️0
jondoeuk jondoeuk 10 months ago
https://www.globenewswire.com/news-release/2024/04/22/2867236/0/en/CRISPR-Therapeutics-to-Present-Oral-Presentation-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-2024-Annual-Meeting.html

EDIT is also pursuing myocilin-related glaucoma https://www.globenewswire.com/news-release/2024/04/22/2867244/0/en/Editas-Medicine-to-Present-Pre-clinical-Data-Demonstrating-Progression-of-in-vivo-Medicines-Pipeline-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting.html
👍️0
OldAIMGuy OldAIMGuy 11 months ago
StockCharts 3 year history with 20% ZigZag reversals................



CRSP seems to be suffering from lack of 'sponsorship' in that the stock has not shown "accumulation" trend along with the price rally since last year's October Low. There's been volume, but not accumulation bias.

Best wishes,
OAG
👍️0
OldAIMGuy OldAIMGuy 11 months ago
Hi MD,
CRSP is now down around 1/3 from its February high. The price is where I usually start to accumulate more shares.

Best wishes,
OAG
👍️0
Monksdream Monksdream 11 months ago
CRSP over $30
👍️0
jondoeuk jondoeuk 11 months ago
Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-american-society-120000624.html
👍️0
Monksdream Monksdream 1 year ago
CRSP new 52 week high
👍️0
Monksdream Monksdream 1 year ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 1 year ago
CRSP new 52 week high
👍️ 1
Monksdream Monksdream 1 year ago
CRSP new 52 week high
👍️ 1
jondoeuk jondoeuk 1 year ago
They entered into an investment agreement for the sale of ~$280 million of its shares to a select group of institutional investors in a registered direct offering, at $71.5 apiece. The financing is being led by EcoR1 Capital and SR One with participation from existing investors and a healthcare specialist investor https://finance.yahoo.com/news/crispr-therapeutics-announces-280-million-133000932.html
👍️0
jondoeuk jondoeuk 1 year ago
EU approval https://finance.yahoo.com/news/european-commission-approves-first-crispr-065900771.html
👍️ 1
Monksdream Monksdream 1 year ago
Didn’t tank like BLUE
Recovered


More analysis from Nanolyze

👍️0
Monksdream Monksdream 1 year ago
So there has been some discussion since my last post
More in this podcast
🌈 1 🍆 1
jondoeuk jondoeuk 1 year ago
Around two months ahead of expectations https://www.globenewswire.com/news-release/2024/01/16/2810298/0/en/CRISPR-Therapeutics-Announces-U-S-Food-and-Drug-Administration-FDA-Approval-of-CASGEVY-exagamglogene-autotemcel-for-the-Treatment-of-Transfusion-Dependent-Beta-Thalassemia.html
👍️ 1
jondoeuk jondoeuk 1 year ago
Strategic Priorities and 2024 Outlook https://finance.yahoo.com/news/crispr-therapeutics-highlights-strategic-priorities-120000043.html
👍️0
jondoeuk jondoeuk 1 year ago
Webcast link https://jpmorgan.metameetings.net/events/healthcare24/sessions/49607-crispr-therapeutics-inc/webcast/general_signin?gpu_only=true&kiosk=true
👍️ 1
jondoeuk jondoeuk 1 year ago
Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-42nd-annual-133000024.html
👍️0

Your Recent History

Delayed Upgrade Clock